IRF2BP2

protein-coding

interferon regulatory factor 2 binding protein 2

Gene summary

This gene encodes an interferon regulatory factor-2 (IRF2) binding protein that interacts with the C-terminal transcriptional repression domain of IRF2. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]

MANE transcript

NM_182972.3

Inheritance

AD

ClinVar variants

P:7U:483B:285

Top phenotype

Immunodeficiency, common variable, 14

gnomAD constraint

pLI —, LoF o/e 0.1

Max pathogenic AF

—

Genomic locus

chr1:234,602,300-234,610,178

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~7.9 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

immunodeficiency, common variable, 14STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0054691

Submitter: PanelApp Australia

immunodeficiency, common variable, 14LIMITED

Inheritance Pattern: Unknown

Disease ID:MONDO:0054691

Submitter: Labcorp Genetics (formerly Invitae)

immunodeficiency, common variable, 14LIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0054691

Submitter: Ambry Genetics

immunodeficiency, common variable, 14LIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0054691

Submitter: ClinGen

IRF2BP2 was first reported in relation to autosomal dominant immunodeficiency, common variable, 14 (CVID 14) in 2016 (Keller MD, et al., 2016, PMID: 27016798). CVID is a clinically and genetically heterogeneous entity, primarily presenting as an antibody deficiency with low levels of serum IgG, IgA, and/or IgM, functional antibody deficiency, and recurrent sinopulmonary bacterial infections. In addition, non-infectious complications linked to underlying immune dysregulation are present in a subset of patients. One missense variant (Ser551Asn) has been reported in one proband in one publication (PMID: 27016798), segregating in two additional affected family members. An additional patient with the IRF2BP2 c.1180A>C; p.Thr394Pro variant has been reported in an individual affected with CIVD in an abstract for the American college of allergy, asthma & immunology 2018 annual scientific meeting (Joseph 2018; https://doi.org/10.1016/j.anai.2018.09.308). This gene-disease association is supported by its role as a transcriptional corepressor, participating in the adaptive immune response by influencing the maintenance, production, and secretion of cytokines (PMID: 21576369), and the alteration of B-cell maturation found in patient cells (PMID: 27016798). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship.

Clinical Genomic Database (CGD)

Immunodeficiency, common variable, 14AD

Manifestation: Allergy/Immunology/Infectious

Intervention: Allergy/Immunology/Infectious

Rationale: Antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial

Refs: 27016798Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to IRF2BP2 variants in ClinVar

7 Conditions Cataloged
not providedTotal: 750
not specifiedTotal: 183
IRF2BP2-related disorderTotal: 37
Immunodeficiency, common variable, 14Total: 32
Varicella, severe recurrentTotal: 1
Immune deficiency, familial variableTotal: 1
Inborn error of immunityTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_182972.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
270
clinvar
2
clinvar
272
missense
445
clinvar
13
clinvar
458
nonsense
1
clinvar
3
clinvar
14
clinvar
18
start loss
0
frameshift
3
clinvar
23
clinvar
26
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total164832832775

Highest pathogenic variant AF is 8.894803e-7

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 12 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_182972.3RefSeqNP_892017.22MANE Select
ENST00000366609.4EnsemblENSP00000355568.32MANE Select
NM_001077397.1RefSeqNP_001070865.12Standard
ENST00000366610.7EnsemblENSP00000355569.32Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Biological Process

  • negative regulation of transcription by RNA polymerase II
  • immature B cell differentiation
  • positive regulation of transcription by RNA polymerase II

Molecular Function

  • RNA polymerase II regulatory region sequence-specific DNA binding
  • DNA-binding transcription activator activity, RNA polymerase II-specific
  • metal ion binding

Cellular Component

  • nucleus
  • nucleoplasm
  • cytoplasm

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000366609
Coding exons
2
Length
5257
Individuals with no LoFs
0
Homozygous LoFs
0
Heterozygous LoFs
0
Defined
0
p
0.00
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.6222132400.8870.00001133624
Missense (PolyPhen)84107.360.782391304
Synonymous-6.281881061.780.000005401263
Loss of Function2.72110.50.09514.53e-7157

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)00.0absent
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Acts as a transcriptional corepressor in a IRF2- dependent manner; this repression is not mediated by histone deacetylase activities (PubMed:12799427). Represses the NFAT1- dependent transactivation of NFAT-responsive promoters (PubMed:21576369). Acts as a coactivator of VEGFA expression in cardiac and skeletal muscles (PubMed:20702774). Plays a role in immature B-cell differentiation (PubMed:27016798). {ECO:0000269|PubMed:12799427, ECO:0000269|PubMed:20702774, ECO:0000269|PubMed:21576369, ECO:0000269|PubMed:27016798}.;
Disease
DISEASE: Immunodeficiency, common variable, 14 (CVID14) [MIM:617765]: A primary immunodeficiency resulting in recurrent sinopulmonary infections since early childhood, and characterized by hypogammaglobulinemia with undetectable IgG and IgA, poor response to vaccination, and decreased levels of switched memory B cells. CVID14 inheritance is autosomal dominant. {ECO:0000269|PubMed:27016798}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.110

Essentials

Essential (CRISPR)
E
Essential (CRISPR2)
S
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.992

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.